Results 11 to 20 of about 97,265 (298)
Sphingolipids in thyroid eye disease
Frontiers in Endocrinology, 2023 Graves’ disease (GD) is caused by an autoimmune formation of autoantibodies and autoreactive T-cells against the thyroid stimulating hormone receptor (TSHR).
Anne Gulbins +3 more
doaj +1 more source
BMC Ophthalmology, 2023 Background Thyroid eye disease is an extrathyroidal manifestation of Graves’ disease and is associated with dry eye disease. This is the first systematic review and meta-analysis to evaluate the role of magnetic resonance imaging lacrimal gland ...
Nicole Tsz Yan Wong +8 more
doaj +1 more source
Multidimensional predictive model for assessing clinical activity in thyroid eye disease. [PDF]
Front Med (Lausanne)Li Y +6 more
europepmc +3 more sources
Canadian Medical Association Journal, 2013 About 90% of patients with thyroid eye disease have Graves hyperthyroidism, but hypothyroidism and euthyroidism can also accompany this condition.[1][1] Eye disease usually develops in patients with hyperthyroidism within the first 1–2 years, but the disease can occur decades later.
Michel J, Belliveau, David R, Jordan
openaire +2 more sources
Frontiers in Bioengineering and Biotechnology, 2023 This study replicated the behavior of intraorbital tissue in patients with thyroid eye disease (TED) based on finite element analysis for general orbital decompression risk evaluation in thyroid eye disease patients. The orbit and intraorbital tissues of
Byeong Cheol Jeong +6 more
doaj +1 more source
Dry eye syndrome in thyroid-associated ophthalmopathy
Oftalʹmologiâ, 2015 Purpose: The pathogenesis of keratoconjunctivitis sicca in patients with thyroid eye disease is presented. The influence of therapy by a HYLO-PARIN® on a condition of a tear film in patients with various forms of thyroid eye disease is assessed. Methods:
A. F. Brovkina +2 more
doaj +3 more sources
Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
Frontiers in Endocrinology, 2022 There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect
Lilly H. Wagner +5 more
doaj +1 more source
Morphometric and volumetric analysis of lacrimal glands in patients with thyroid eye disease
Scientific Reports, 2023 Assessment of morphometric and volumetric changes in lacrimal glands in thyroid eye disease, its clinical manifestations in relation of disease progression.
Ana Starčević +9 more
doaj +1 more source
Journal of Medical Case Reports, 2022 Background Teprotumumab is a novel treatment that reduces inflammation and symptoms caused by thyroid eye disease. There are limited data on teprotumumab’s effect on intraocular pressure.
Matthew Chu +4 more
doaj +1 more source